Related Experiment Video
Updated: May 29, 2026
08:36
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
Leisure activities, cognition and dementia
Hui-Xin Wang1, Weili Xu, Jin-Jing Pei
1Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Gävlegatan 16, 113 30 Stockholm, Sweden. huixin.wang@ki.se
Biochimica Et Biophysica Acta
|September 21, 2011
Summary
Engaging in leisure activities, particularly mental and physical ones, shows promise in protecting cognitive function and reducing dementia risk. Standardized research methods are crucial for future studies.
Area of Science:
- Neuroscience
- Gerontology
- Public Health
Background:
- Growing evidence suggests a link between leisure activities and cognitive health.
- Understanding the mechanisms and effectiveness of different activities is vital for aging populations.
Purpose of the Study:
- To systematically review longitudinal studies on leisure activities, cognitive function, and dementia.
- To evaluate the biological plausibility and limitations of existing research.
- To focus on mental, physical, and social activities.
Main Methods:
- Systematic review of longitudinal studies (≥2 years follow-up) published 1991-2011.
- Included studies on leisure activities and cognition (n=29) or dementia (n=23).
- Considered intervention studies and biological mechanisms.
Main Results:
- Mental activities consistently show a protective effect on cognitive function.
- Observational studies robustly link mental activity to reduced dementia risk, though clinical trials are inconsistent.
- Physical activity shows a protective effect in most observational studies, less so in interventions.
- Evidence for other leisure activities is limited and inconsistent.
Conclusions:
- Mental and physical leisure activities appear beneficial for cognitive health and dementia prevention.
- Further research requires standardized assessment of activities and cognitive outcomes.
- Well-designed, long-term studies are needed to clarify these associations.
Related Concept Videos
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...